Name Development Level Target Family
Acetylcholinesterase Tclin Enzyme
Muscarinic acetylcholine receptor M2 Tclin GPCR
Muscarinic acetylcholine receptor M3 Tclin GPCR
Name Description
neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
neostigmine